共 163 条
[11]
Afzal R(2006)Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2203-2216
[12]
Mehta SR(2007)Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2344-2351
[13]
Stone GW(1991)Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), phase II trial Ann Intern Med 115 256-265
[14]
Witzenbichler B(2004)ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) Circulation 110 588-636
[15]
Guagliumi G(2007)ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiogra
[16]
Peruga JZ(2004)Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology Eur Heart J 25 166-181
[17]
Brodie BR(2011)Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3‑year results from a multicentre, randomised controlled trial Lancet 377 2193-2204
[18]
Dudek D(2015)Bivalirudin for acute coronary syndromes: premises, promises and doubts Thromb Haemost 113 698-707
[19]
Valgimigli M(2015)Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: an updated meta-analysis of 10,350 patients from five randomized clinical trials Eur Heart J Acute Cardiovasc Care 5 253-262
[20]
Frigoli E(2014)Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials Lancet 384 599-606